Alison Lansley is a Principal Lecturer in Pharmaceutics at the University of Brighton (UoB). She obtained her degree in Pharmacy and PhD in mucociliary clearance from the UoB and then undertook post-doctoral positions at UCLA (cellular control of ciliary activity) and, subsequently, King’s College London (the use of airway cell lines as drug absorption models of the lung) where she then took up a lectureship. Following a career break, she was awarded a Daphne Jackson Fellowship which she undertook at the University of Sussex before accepting her current position at the UoB. Her research interests include the use of in vivo-reflective in vitro models to study the effect of mucus on drug/particle deposition behaviour and absorption in the respiratory tract, factors affecting mucociliary clearance and inhalation toxicity.
She has previously led the MPharm programme at the UoB and is a Senior Fellow of the Higher Education Academy, a Fellow of the Academy of Pharmaceutical Sciences (APS) and a member of the APS Biopharmaceutics Focus Group and the Nasal Research Focus Group. She teaches biopharmaceutics and formulation science to undergraduate and postgraduate students and has supervised PhD students and postdoctoral researchers with funding from research councils, charities, and industry. She has published papers and book chapters on pulmonary and nasal drug delivery.